Replies to post #102637 on Biotech Values

[DewDiligence]

So PPHM has facilities to manufacture biopharmaceuticals—how is that enough to make them a serious player in FoB’s?

I think the answer is that PPHM is defining an FoB as almost any biopharmaceutical—whether or not the development program is based on characterizing and reverse-engineering another company’s product. By this definition, PPHM’s claims with respect to FoB’s are essentially meaningless, IMO.

[masterlongevity]

'and was responsible for DNA’s obtaining marketing approval for 17 drug products including Rituxan, Herceptin, Avastin, and Lucentis, and 3 mfg. facilities… '

although a nice man, Mr garnick had very little to do with any of these approvals. he never stepped foot in front of the FDA on at least 4/4 f those drug approvals